Ranivisio 10 mg/mL
Ranivisio 10 mg/mL is a medicine authorised by Swissmedic under authorisation number 69068. The authorisation holder is Bioeq AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 04 August 2023 and the authorisation is limited until 03 August 2028. ATC code S01LA04 places the medicine in the group Ophthalmologicals.
| Authorisation number | 69068 |
|---|---|
| Name | Ranivisio 10 mg/mL |
| Full name | Ranivisio 10 mg/mL, Injektionslösung in Durchstechflasche |
| Authorisation holder | Bioeq AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01LA04 |
| First authorisation | 04 August 2023 |
| Authorisation validity | 03 August 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ranivisio 10 mg/mL, Injektionslösung in Durchstechflasche | B | 04 August 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | S01LA04 | 11.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ranivisio 10 mg/mL authorised in Switzerland?
Yes. Ranivisio 10 mg/mL is authorised by Swissmedic under authorisation number 69068, data as of 01 September 2026. The authorisation is limited until 03 August 2028.
Which dispensing category does Ranivisio 10 mg/mL have?
Ranivisio 10 mg/mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ranivisio 10 mg/mL?
The authorisation holder is Bioeq AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.